These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3084413

  • 1. Inhibitory effects of ethoxyquin, 4,4'-diaminodiphenylmethane and acetaminophen on rat hepatocarcinogenesis.
    Masui T, Tsuda H, Inoue K, Ogiso T, Ito N.
    Jpn J Cancer Res; 1986 Mar; 77(3):231-7. PubMed ID: 3084413
    [Abstract] [Full Text] [Related]

  • 2. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases.
    Kensler TW, Egner PA, Davidson NE, Roebuck BD, Pikul A, Groopman JD.
    Cancer Res; 1986 Aug; 46(8):3924-31. PubMed ID: 2873884
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator.
    Rao MS, Lalwani ND, Watanabe TK, Reddy JK.
    Cancer Res; 1984 Mar; 44(3):1072-6. PubMed ID: 6692393
    [Abstract] [Full Text] [Related]

  • 4. Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxyquin in induction of foci of rat liver cells containing the placental form of glutathione S-transferase.
    Thamavit W, Tatematsu M, Ogiso T, Mera Y, Tsuda H, Ito N.
    Cancer Lett; 1985 Jul; 27(3):295-303. PubMed ID: 2861889
    [Abstract] [Full Text] [Related]

  • 5. Effects of alpha-tocopherol, phenobarbital, and butylated hydroxyanisole during promotion of diethylnitrosamine-initiated rat hepatocarcinogenesis.
    Hendrich S, Duitsman P, Krueger SK, Jackson A, Myers RK.
    Nutr Cancer; 1991 Jul; 15(1):53-62. PubMed ID: 2017399
    [Abstract] [Full Text] [Related]

  • 6. Modification by antioxidants and p,p'-diaminodiphenylmethane of 7,12-dimethylbenz[a]anthracene-induced carcinogenesis of the mammary gland and ear duct in CD rats.
    Hirose M, Masuda A, Inoue T, Fukushima S, Ito N.
    Carcinogenesis; 1986 Jul; 7(7):1155-9. PubMed ID: 3087646
    [Abstract] [Full Text] [Related]

  • 7. Modification of carcinogenesis by antioxidants and other compounds.
    Tsuda H, Fukushima S, Imaida K, Sakata T, Ito N.
    Acta Pharmacol Toxicol (Copenh); 1984 Jul; 55 Suppl 2():125-43. PubMed ID: 6148834
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effect of butylated hydroxyanisole and ethoxyquin on the induction of neoplastic lesions in rat liver after an initial treatment with N-ethyl-N-hydroxyethylnitrosamine.
    Ito N, Tsuda H, Sakata T, Hasegawa R, Tamano S.
    Gan; 1983 Aug; 74(4):466-8. PubMed ID: 6628899
    [Abstract] [Full Text] [Related]

  • 9. Effects of butylated hydroxyanisole, butylated hydroxytoluene, and NaCl on gastric carcinogenesis initiated with N-methyl-N'-nitro-N-nitrosoguanidine in F344 rats.
    Shirai T, Fukushima S, Ohshima M, Masuda A, Ito N.
    J Natl Cancer Inst; 1984 May; 72(5):1189-98. PubMed ID: 6585594
    [Abstract] [Full Text] [Related]

  • 10. Different modifying response of butylated hydroxyanisole, butylated hydroxytoluene, and other antioxidants in N,N-dibutylnitrosamine esophagus and forestomach carcinogenesis of rats.
    Fukushima S, Sakata T, Tagawa Y, Shibata MA, Hirose M, Ito N.
    Cancer Res; 1987 Apr 15; 47(8):2113-6. PubMed ID: 3829000
    [Abstract] [Full Text] [Related]

  • 11. Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci development in the liver of rats.
    Imaida K, Fukushima S, Shirai T, Ohtani M, Nakanishi K, Ito N.
    Carcinogenesis; 1983 Apr 15; 4(7):895-9. PubMed ID: 6135514
    [Abstract] [Full Text] [Related]

  • 12. Modifying effects of butylated hydroxyanisole, ethoxyquin and acetaminophen on induction of neoplastic lesions in rat liver and kidney initiated by N-ethyl-N-hydroxyethylnitrosamine.
    Tsuda H, Sakata T, Masui T, Imaida K, Ito N.
    Carcinogenesis; 1984 Apr 15; 5(4):525-31. PubMed ID: 6142774
    [Abstract] [Full Text] [Related]

  • 13. [Antimicrobial activity of phenolic antioxidants].
    Turcotte P, Saheb SA.
    Can J Microbiol; 1978 Nov 15; 24(11):1306-20. PubMed ID: 743641
    [Abstract] [Full Text] [Related]

  • 14. Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione.
    Kensler TW, Egner PA, Trush MA, Bueding E, Groopman JD.
    Carcinogenesis; 1985 May 15; 6(5):759-63. PubMed ID: 3924431
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effects of antioxidants on N-bis(2-hydroxypropyl)nitrosamine-induced lung carcinogenesis in rats.
    Hasegawa R, Furukawa F, Toyoda K, Takahashi M, Hayashi Y, Hirose M, Ito N.
    Jpn J Cancer Res; 1990 Sep 15; 81(9):871-7. PubMed ID: 2121688
    [Abstract] [Full Text] [Related]

  • 16. Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxyquin for promotion of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
    Fukushima S, Ogiso T, Kurata Y, Hirose M, Ito N.
    Cancer Lett; 1987 Jan 15; 34(1):83-90. PubMed ID: 3802071
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effects of KAT-681, a liver-selective thyromimetic, on development of hepatocellular proliferative lesions in rats induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
    Hayashi M, Ohnota H, Tamura T, Kuroda J, Shibata N, Akahane M, Moriwaki H, Machida N, Mitsumori K.
    Arch Toxicol; 2004 Aug 15; 78(8):460-6. PubMed ID: 15034639
    [Abstract] [Full Text] [Related]

  • 18. Effect of butylated hydroxytoluene and butylated hydroxyanisole on the mutagenicity of 3,2'-dimethyl-4-aminobiphenyl.
    Reddy BS, Sharma C, Mathews L.
    Nutr Cancer; 1983 Aug 15; 5(3-4):153-8. PubMed ID: 6366755
    [Abstract] [Full Text] [Related]

  • 19. Dose-related inhibition of aflatoxin B1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene.
    Williams GM, Tanaka T, Maeura Y.
    Carcinogenesis; 1986 Jul 15; 7(7):1043-50. PubMed ID: 2872975
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of neoplastic development in rat liver, kidney, oesophagus and forestomach by 4,4'-diaminodiphenylmethane administration.
    Tsuda H, Ogiso T, Hasegawa R, Imaida K, Masui T, Ito N.
    Carcinogenesis; 1987 May 15; 8(5):719-22. PubMed ID: 3581430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.